Drug recall · January 18, 2023
Rifampin Capsules recall
Why: Failed Impurities/Degradation specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, Repackaged NDC 70518-2404-00.
- Lots / codes
Lot #: J0599794-022322, exp. date 02/28/2023; J0621369-052622, exp. date 06/30/2023
- Quantity
- 132 Cards of 30 = 3960 Tablets
- Company
- RemedyRepack Inc., Indiana, PA
- Distribution
- Product was distributed to one account in PA.
- Initiated
- December 20, 2022 · Voluntary: Firm initiated
- Classified
- January 6, 2023
- Reported
- January 18, 2023
- Ended
- March 3, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rifampin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.